Collectively, our data underscore the importance of CRF as a neuromodulator/neurotransmitter and provides a mechanistic underpinning for stress-induced tau-P and work that implicates CRF as a target for therapeutic intervention in AD. The gene discussed is MAPT; the disease is Alzheimer disease.